International Journal of Experimental Dental Science

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2015 ) > List of Articles

RESEARCH ARTICLE

Dynamics of Matrix Metalloproteinases in the Oral Environment

Regina TC Tandelilin

Citation Information : Tandelilin RT. Dynamics of Matrix Metalloproteinases in the Oral Environment. Int J Experiment Dent Sci 2015; 4 (1):53-57.

DOI: 10.5005/jp-journals-10029-1095

License: CC BY-SA 3.0

Published Online: 01-06-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Tandelilin RTC, Saini R. Dynamics of Matrix Metalloproteinases in the Oral Environment. Int J Experiment Dent Sci 2015;4(1):53-57.


PDF Share
  1. Oral sex, oral health and orogenital infections. J Global Infect Dis 2010;2(1):57-62.
  2. Periodontitis: a risk for delivery of premature labor and low birth weight infants. J Nat Sci Biol Med 2011;2(1):50.52.
  3. Dental Air Force home dental cleaning system: a revolutionary oral hygiene device to prevent systemic diseases caused by periodontal infection. Int J Med Res Health Sci 2013;2(3):431.438.
  4. A clinical and microbiological study to evaluate the effect of dietary supplement of coenzyme Q10 in nonsurgical treatment outcome of chronic periodontitis patients after phase 1 periodontal therapy. Eur J Gen Dent 2014;3(3):194-198.
  5. Therapeutics of stem cells in periodontal regeneration. J Nat Sc Biol Med 2011;2(1):38-42.
  6. The biology of matrix metalloproteinases: review FOB 2002;10(1):1-6.
  7. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4(2):197-250.
  8. Matrix metalloproteinase inhibitors: current developments and future perspectives. Oncologist 2001;6(5):415-427.
  9. Matrix turnover. J Orth 2000 Sep;27(3):227-233.
  10. The role of cell adhesion molecules in craniofacial development. J Royal College of Surg Edinburg 1998 Aug;43(4):223-229.
  11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 2003 May 2;92(8):827-839.
  12. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 1991 May;5(8):2145-2154.
  13. The collagen substratespecificity of rat uterus collagenase. J Biol Chem 1983;258(23): 4162-4165.
  14. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Bio 2000;19(7):623-629.
  15. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 1994 Feb 15;56(4):500-505.
  16. Matrix metalloproteinases. USA: Academic Press; 1998.
  17. Expression of collagenase in IV (basement membrane collagenase)activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst 1985 Jul; 75(1):99-103.
  18. An investigation of preferential fibroblast wound repopulation using a novel in vitro wound model. J Periodontal 1997 Nov;68(11):1063-1069.
  19. TIMP-2 mediates cell surface binding of MMP-2. Adv Exp Med Bio 1996;389:295-304.
  20. Molecular regulation of cellular invansion-role of gelatinase A and TIMP-2. Biochem Cell Biol 1996;74(6):823-831.
  21. J Biol Chem 1990 Dec;265(36):22342-22347.
  22. Role of matrix metalloproteinases in human periodontal diseases. J Periodontal 1993 May;64(Suppl 5):474-484.
  23. Binding of gelatinase A and B to-type-I collagen and other matrix components. J Biochem 1995 Jul 1;309(Pt 1):299-306.
  24. Molecular cloning of murine 72 kDa type IV collagenase and its expression during mouse development. J Biol Chem 1992 Apr;267(11):7856-7862.
  25. Mechanisms of activation of tissue procolagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 1990;29(44): 10261-10270.
  26. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 2000 Sep;60(17):4745-4751.
  27. Identification and characterization of human endometase(matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 2000 Jul 7;275(27):20540-20544.
  28. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993 Nov;268(32):23824-23829.
  29. Metalloelastase is required for macrophage-mediated proteolysis and matrix invansion in mice. Proc Natl Acad Sci USA 1996 Apr;93(9):1942-3946.
  30. Identication and characterization of a novel human matrix metalloproteinase with unique structural characteristic, chromosomal location, and tissue distribution. J Biol Chem 1997 Feb;272(7):4281-4286.
  31. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 2001 Mar;276(13):10134-10144.
  32. Trendsin molecular medicine: matrix metalloproteinases and their inhibitors in tumour growth and invansion. Annals of Medicine 1999;31(1): 34-45.
  33. Matrix-metalloproteinaes and metastasis. Cancer Chemotherapy and Pharmachology 1999 May;43(Suppl 1):42-51.
  34. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies. Journal of the Royal College of Surgeons of Edinburg 1997;42(3):154-160.
  35. TIMP-2 expression modulates human melanoma cell adhesion and motility. Ann NY Acad Sci 1994;732(1):233-247.
  36. Structural biochemistry and activation of matrix metalloproteinases, Current Opinion in Cell Biol 1993;5(5):891-897.
  37. Matric metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267(6):3581-3584.
  38. Activation of recombinant membrane type 1- matrix metalloproteinase (MT-1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP-2). FEBS Letters 1996 Sep;393(1):101-104.
  39. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in development and disease of oral tissues. Dent in Japan 1998;34:167-177.
  40. Cytokin-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation. J Periodontol Res 1996;31(7):483-488.
  41. Effect of lead, cadmium and zinc on the activity of enamel matrix proteinases in vitro. Eur J Oral Sci 2000;108(4):327-334.
  42. Mutation of the matrix metalloproteinase 2 gene (MMP-2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001 Jul;28(3):261-265.
  43. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1992;315:768-771.
  44. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroidpotentiating activity. FEBS Lett 1992 Jan 20;298(2):231-234.
  45. Growth-promoting activity of tissue inhibitor of metalloproteinases- 1 (TIMP-1) for a wide range of cells: a possible new growth factors in serum. FEBS Lett 1992 Feb 17;298(1): 29-32.
  46. Cell growth-promoting activity of tissue inhibitor of metalloproteinases- 2 (TIMP-2). J Cell Sci 1994;107:2373-2379.
  47. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74(2):111-112.
  48. Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993 Nov;157(2):351-356.
  49. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994 Jul;370(6484):61-65.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.